Basis: Trailing twelve months (TTM), to the latest fiscal quarter end. Source: stored company filings and market data; unavailable inputs remain N/A.
Is the return on invested capital (ROIC) high or low?
The return on invested capital (ROIC) of -77.55% is 32% above its 5-year average of -114.16%, near the high end of its 5-year range (-332.93%–-15.85%).
As of the fiscal period ended Tuesday, June 30, 2026. 42.13% above its 12-month average of -134.02%.
Trailing-twelve-month return on invested capital at each fiscal quarter end; no daily interpolation. Q2 FY2026 (2026-06-30): -77.55%.
RETURN ON INVESTED CAPITAL (ROIC)
-77.55%
RETURN ON INVESTED CAPITAL (ROIC) AVG TTM
-134.02%
RETURN ON INVESTED CAPITAL (ROIC) AVG 3Y
-150.74%
RETURN ON INVESTED CAPITAL (ROIC) AVG 5Y
-114.16%
RETURN ON INVESTED CAPITAL (ROIC) AVG 10Y
N/A
RETURN ON INVESTED CAPITAL (ROIC) AVG 15Y
N/A
RETURN ON INVESTED CAPITAL (ROIC) AVG 20Y
N/A
CURRENT VS TTM AVG
+42.13%
CURRENT VS 3Y AVG
+48.56%
CURRENT VS 5Y AVG
+32.07%
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
-27.19%
median of 428 covered companies
CURRENT VS SECTOR MEDIAN
-185.22%
vs the sector median at left
Bluejay Diagnostics, Inc.
Market Cap
$787624.00
Return on Invested Capital (ROIC)
-77.55%
TTM Avg
-134.02%
3Y Avg
-150.74%
5Y Avg
-114.16%
Market Cap
$707297.00
Return on Invested Capital (ROIC)
4.47%
TTM Avg
-1129.41%
3Y Avg
-780.32%
5Y Avg
-986.52%
Market Cap
$878396.00
Return on Invested Capital (ROIC)
-78.01%
TTM Avg
-90.63%
3Y Avg
-141.82%
5Y Avg
-116.81%
Market Cap
$885939.00
Return on Invested Capital (ROIC)
N/A
TTM Avg
-416.12%
3Y Avg
-338.16%
5Y Avg
-243.59%
Market Cap
$888387.00
Return on Invested Capital (ROIC)
-343.55%
TTM Avg
-272.49%
3Y Avg
-270.70%
5Y Avg
-191.72%
Market Cap
$570131.00
Return on Invested Capital (ROIC)
-41.92%
TTM Avg
-267.75%
3Y Avg
-175.00%
5Y Avg
-127.51%
Market Cap
$1.02M
Return on Invested Capital (ROIC)
-59.81%
TTM Avg
-3.58%
3Y Avg
-5.96%
5Y Avg
-5.96%
Market Cap
$1.11M
Return on Invested Capital (ROIC)
-60.41%
TTM Avg
-162.02%
3Y Avg
-321.37%
5Y Avg
-223.75%
Market Cap
$1.14M
Return on Invested Capital (ROIC)
-9.45%
TTM Avg
-4.19%
3Y Avg
5.39%
5Y Avg
5.39%
| NAME | MARKET CAP | RETURN ON INVESTED CAPITAL (ROIC) | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Bluejay Diagnostics, Inc. (BJDX) | $787624.00 | -77.55% | -134.02% | -150.74% | -114.16% |
| CDT Equity Inc. (CDT)vs › | $707297.00 | 4.47% | -1129.41% | -780.32% | -986.52% |
| Bone Biologics Corporation (BBLG)vs › | $878396.00 | -78.01% | -90.63% | -141.82% | -116.81% |
| GlucoTrack, Inc. (GCTK)vs › | $885939.00 | N/A | -416.12% | -338.16% | -243.59% |
| Decoy Therapeutics Inc. (DCOY)vs › | $888387.00 | -343.55% | -272.49% | -270.70% | -191.72% |
| HCW Biologics Inc. (HCWB)vs › | $570131.00 | -41.92% | -267.75% | -175.00% | -127.51% |
| Aspire Biopharma Holdings, Inc. (ASBP)vs › | $1.02M | -59.81% | -3.58% | -5.96% | -5.96% |
| Clearmind Medicine Inc. (CMND)vs › | $1.11M | -60.41% | -162.02% | -321.37% | -223.75% |
| Cellyan Biotechnology Co., Ltd (HKPD)vs › | $1.14M | -9.45% | -4.19% | 5.39% | 5.39% |
| IM Cannabis Corp. (IMCC)vs › | $1.17M | -128.95% | -69.60% | -67.51% | -50.89% |
ROIC
-77.6%
ROE
-77.2%
ROIC = NOPAT / Invested Capital, where NOPAT = Operating Income × (1 − effective tax rate) and Invested Capital = Total Assets − (Current Liabilities − Short-Term Debt)
Return on invested capital measures the after-tax operating return a company earns on the capital invested in the business. TGMCharts computes it from reported statements: trailing-twelve-month operating income after tax, over invested capital at the latest balance sheet — total assets less the non-interest-bearing current liabilities (payables, accruals, deferred revenue) that fund them; short-term debt stays in the capital base. The tax rate is the period's own effective rate (income tax ÷ pretax income), capped at 45%; when pretax income is zero or negative, or the tax line is a net benefit, no tax is deducted — the operating figure is shown untaxed rather than adjusted by an assumed rate. Not shown for banks, insurers or funds.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | RETURN ON INVESTED CAPITAL (ROIC) |
|---|---|
| 2026-06-30 | -77.55% |
| 2026-03-31 | -167.28% |
| 2025-12-31 | -115.88% |
| 2025-09-30 | -186.45% |
| 2025-06-30 | -122.93% |
| 2025-03-31 | -167.38% |
| 2024-12-31 | -122.62% |
| 2024-09-30 | -110.51% |
| 2024-06-30 | -101.13% |
| 2024-03-31 | -283.43% |
| 2023-12-31 | -332.93% |
| 2023-09-30 | -190.55% |
| 2023-06-30 | -163.22% |
| 2023-03-31 | -104.87% |
| 2022-12-31 | -78.43% |
| 2022-09-30 | -58.08% |
| 2022-06-30 | -37.37% |
| 2022-03-31 | -26.98% |
| 2021-12-31 | -15.85% |
| 2021-09-30 | -84.30% |
| 2021-06-30 | -68.50% |
| 2020-12-31 | -164.37% |
